Abstract
Glioblastoma is the most aggressive type of tumor that affects the central nervous system (CNS), normally treated with temozolomide (TMZ) concomitantly with surgical resection and radiotherapy, and may also be used in combined therapies, such as with cisplatin (CP). However, among the resistance mechanisms to these chemotherapeutic agents, we find Translesion Synthesis (TLS) polymerases t…